SCHEMBL10265779

SCHEMBL10265779

COC(=O)c1sc(C(C)C)cc1N(CC(=O)N1CCOCC1)C(=O)[C@H]1CC[C@H](C)CC1

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP2E1 P05181 1/20 0.57
▸ FKBP1A P62942 4/20 0.35
▸ EPHX2 P34913 1/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ GAA P10253 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ POLB P06746 2/20 0.33
▸ MCOLN3 Q8TDD5 1/20 0.33
▸ APOBEC3G Q9HC16 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10265780 0.90 CYP2E1 (0.69) CYP2E1FKBP1AEPHX2ALDH1A1GAA
SCHEMBL10266124 0.89 CYP2E1 (0.58) CYP2E1FKBP1AEPHX2ALDH1A1GAA
SCHEMBL10265447 0.88 CYP2E1 (0.58) CYP2E1FKBP1AEPHX2ALDH1A1SMN1; SMN2
SCHEMBL15130860 0.88 CYP2E1 (0.58) CYP2E1FKBP1AEPHX2ALDH1A1SMN1; SMN2
SCHEMBL10265449 0.88 CYP2E1 (0.61) CYP2E1FKBP1AEPHX2ALDH1A1GAA
SCHEMBL15123790 0.86 CYP2E1 (0.66) CYP2E1FKBP1AEPHX2ALDH1A1GAA
SCHEMBL15123792 0.86 CYP2E1 (0.66) CYP2E1FKBP1AEPHX2ALDH1A1GAA
SCHEMBL318214 0.85 CYP2E1 (0.59) CYP2E1FKBP1AEPHX2ALDH1A1SMN1; SMN2
SCHEMBL10265151 0.84 CYP2E1 (0.64) CYP2E1EPHX2ALDH1A1GAASMN1; SMN2
SCHEMBL319216 0.84 CYP2E1 (0.64) CYP2E1EPHX2ALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012006055-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-01-12 — — WO disclosed
Send feedback